eriodictyol has been researched along with chlorogenic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karioti, A; Konstantinopoulou, M; Skaltsa, H; Skaltsas, S | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Albiñana, CB; Brynda, J; Fanfrlík, J; Flieger, M; Hodek, J; Karlukova, E; Konvalinka, J; Kožíšek, M; Machara, A; Majer, P; Radilová, K; Weber, J; Zima, V | 1 |
| Gawas, UB; Majik, MS; Mandrekar, VK | 1 |
1 review(s) available for eriodictyol and chlorogenic acid
| Article | Year |
|---|---|
Next generation quorum sensing inhibitors: Accounts on structure activity relationship studies and biological activities.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Biofilms; Cobalt; Coordination Complexes; Drug Design; Furans; Quorum Sensing; Staphylococcus aureus; Structure-Activity Relationship | 2020 |
3 other study(ies) available for eriodictyol and chlorogenic acid
| Article | Year |
|---|---|
Sesquiterpene lactones from Anthemis altissima and their anti-Helicobacter pylori activity.
Topics: Asteraceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Greece; Helicobacter pylori; Lactones; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Sesquiterpenes; Stereoisomerism | 2003 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
Topics: Antiviral Agents; Crystallography, X-Ray; Drug Evaluation, Preclinical; Endonucleases; Enzyme Assays; Enzyme Inhibitors; Flavonoids; Influenza A virus; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Protein Domains; RNA-Dependent RNA Polymerase; Structure-Activity Relationship; Viral Proteins | 2020 |